Laddar...
P6
Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ERα) positive breast cancer (Goldhirsch et al., 2013). Despite well-known advantages of tamoxifen treatment, approximately one third of patients experience a relapse or disease pr...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Elsevier
2015-11-01
|
| Serie: | EJC Supplements |
| Länkar: | http://www.sciencedirect.com/science/article/pii/S1359634915000051 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|